July 2021 - Page 21 of 41

MondayJul 19, 2021 9:51 am

QualityStocksNewsBreaks – TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Provides Update on New Las Vegas Facility

TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) has announced that work on its new facilities, which are located in Las Vegas and designed to ensure the company has ample capacity to meet forecast demand, is moving forward. Specifically, the company stated that all processing equipment, including mixers, shredders and conveyor belts, has been successfully moved into the new manufacturing facility with plans for additional machinery, including finishing equipment, to arrive in the coming weeks. Based on those dates, the company noted that the new manufacturing facility should be operational in August 2021. The announcement also noted that the new…

MondayJul 19, 2021 9:30 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Leverages Pandemic-Induced Trends, Changes in the Food & Beverage Industry Through Strategic Partnerships

PlantX Life recently launched as a seller on both Walmart Canada Marketplace and Hudson’s Bay Marketplace The launches appear to be leveraging the changes and trends brought about by the COVID-19 pandemic In addition, the agreements are part of PlantX’s growth strategy The company will offer thousands of its products on both platforms As the COVID-19 pandemic upended multiple aspects of life in Canada, it did not spare the retail industry. Here, it forced Canadians to rethink how, where and when they shop, with the paramount consideration in their decision-making process being their personal and family health and safety. Shopping…

MondayJul 19, 2021 9:30 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Acquisition Leads to Milestone Achievement, Positive Pre-Clinical Results

CYBN subsidiary Adelia Therapeutics has reached earn-out milestones. Adelia’s earn-out milestones contributed to positive preclinical results with multiple proprietary psychedelic molecules. Cybin’s development of these compounds differentiates it from companies focused on naturally occurring psychedelic compounds. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, has announced that earn-out milestones have been reached by its wholly controlled subsidiary Adelia Therapeutics Inc. These milestones, which were for the period commencing Jan. 1, 2021, add value to Cybin’s pipeline of novel psychedelic compounds (https://ibn.fm/Y1YPb). "These positive catalysts continue to provide the necessary data required to demonstrate that Cybin’s…

MondayJul 19, 2021 9:30 am

Golden Triangle Ventures Inc. (GTVH) Working to Develop, Commercialize First-of-Its-Kind Technology

GTVH, HyFrontier Technologies working together to offer a patent-pending hydrogen and oxygen delivery system for agriculture. Company has seen recent developments that could significantly benefit the entire agricultural industry. Duplicating enhanced-growth thunderstorms cause can reduce need for crop rotations, helping millions of people avoid starvation. A little more than a month after announcing its formal purchase agreement with HyFrontier Technologies (https://ibn.fm/RZkbo), Golden Triangle Ventures (OTC: GTVH) is making good on its commitment to pursue ventures in the technology sector to provide advanced technology for the modern era. GTVH and HyFrontier Technologies are working together to offer a patent-pending, first-of-its-kind hydrogen…

MondayJul 19, 2021 9:00 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Reports Successful Implementation and Testing of HealthTab(TM) in Shoppers Drug Mart(R) Locations

The program’s initial focus is to support those at risk or already diagnosed with diabetes or cardiovascular disease, offering better health management and quality of life In the United States, approximately 88 million adults live with prediabetes, and as many as 84% do not know they have it. It is estimated that by 2030, 13.6 million Canadians will be diabetic or prediabetic The global point-of-care diagnostics testing market was valued at $30.45 billion in 2021 and is anticipated to grow at a CAGR of 3.25%, resulting in a revenue forecast of $35.74 billion by 2028 Avricore Health Inc. (TSX.V: AVCR)…

MondayJul 19, 2021 9:00 am

DealMaker Webinar Features Industry Experts, Takes Closer Look at Reg A+ Distribution Channels

Industry experts share expertise, insight in next DealMaker webinar. Successful Reg A+ offerings tell their stories across multiple mediums. DealMaker is building a reputation for its ability to offer services that support companies across a wide array of needs. With its mission of delivering speed, innovation and efficiency to global capital markets in mind, DealMaker has scheduled its next webinar. Slated for July 20, 2021, at 12 noon ET, the event will feature Don Yocham, executive director of the National Institute of Cannabis Investors, and Ryan Bradford, director of digital marketing at Creative Direct Marketing Group as well as DealMaker’s…

FridayJul 16, 2021 1:48 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Stands Distinct in Precision Medicine

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is leveraging its unique, historical database of the drug responses of over 150,000 patient tumors to build data-driven predictive models of tumor drug response. These models will provide actionable insights critical to both new drug development and individualizing patient treatment. “While others must wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine,” a recent article reads. “Predictive Oncology presently has the clinical information, including tumor drug response data and…

FridayJul 16, 2021 1:44 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Enters Agreement with University of Michigan for Testing of Latest Psychedelic Drug Candidate

San Diego-based Tryp Therapeutics is developing new drug candidates with the aim of treating medical conditions that currently have limited effective therapy Tryp has solidified an agreement with the University of Michigan’s Chronic Pain & Fatigue Research Center and the Center for Consciousness Science to test synthetic psychedelic drug candidate TRP-8803 to advance its use in upcoming clinical trials The Company has also established an agreement with the University of Florida to test its lead drug candidate — TRP-8802 — for certain eating disorders Psychedelics are beginning to gain new respect and attention for addressing select neurological conditions as scientists,…

FridayJul 16, 2021 1:17 pm

QualityStocksNewsBreaks – Infobird Software Co. Ltd.’s (NASDAQ: IFBD) SaaS Solutions Gaining Recognition from Reputable Retail Enterprises

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, recently announced its platform would provide Zu Li Jian, a pioneer in the production of footwear for the elderly in China, with cloud-native, autonomous and controllable source code resources to create flexible customization and expansion for Zu Li Jian’s own e-shopping platform. Through IFBD’s upgrade, Zu Li Jian’s customer service platform will now boast high stability, high concurrency and high expansion capability, making it responsive to future needs and business peaks. “The announcement follows on the heels of a similar intelligent B2B collaboration that will deliver enhanced customer service…

FridayJul 16, 2021 1:07 pm

QualityStocksNewsBreaks – G5 Entertainment AB (GENTF) Featured in Earnings Preview Research from Sidoti

Revenue mix and efficiencies expecting to drive profit expansion G5 Entertainment (OTCQX: GENTF) was featured in a company-sponsored research earnings preview note published by Sidoti & Company, LLC. The report reads, “We anticipate 2Q:21 revenue roughly flat year over year, with growth in wholly owned games of 9% and a decline of 15% in licensed games, producing a mix of 60% wholly owned and 40% licensed, evolving from a 54%/46% respective split in 2Q:20.” To access the full report, visit https://ibn.fm/tARXG About G5 Entertainment AB (OTCQX: GENTF) G5 Entertainment develops and publishes high quality free-to-play games for smartphones, tablets and…

Site Search

Company Search

Month: July 2021

QualityStocksNewsBreaks – TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Provides Update on New Las Vegas Facility

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Leverages Pandemic-Induced Trends, Changes in the Food & Beverage Industry Through Strategic Partnerships

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Acquisition Leads to Milestone Achievement, Positive Pre-Clinical Results

Golden Triangle Ventures Inc. (GTVH) Working to Develop, Commercialize First-of-Its-Kind Technology

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Reports Successful Implementation and Testing of HealthTab(TM) in Shoppers Drug Mart(R) Locations

DealMaker Webinar Features Industry Experts, Takes Closer Look at Reg A+ Distribution Channels

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Stands Distinct in Precision Medicine

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Enters Agreement with University of Michigan for Testing of Latest Psychedelic Drug Candidate

QualityStocksNewsBreaks – Infobird Software Co. Ltd.’s (NASDAQ: IFBD) SaaS Solutions Gaining Recognition from Reputable Retail Enterprises

QualityStocksNewsBreaks – G5 Entertainment AB (GENTF) Featured in Earnings Preview Research from Sidoti

Market Basics

Newsletter Publishers

Public Companies